Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 27, 2026Scientific ReportsOpen Access

The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlaa M. MostafaYFYasser FouadNANadia Abdelaaty Abdelkader

Discussion

Loading...

Member takes

Overview

Cross-sectional study assesses liver fibrosis in chronic hepatitis B patients with metabolic dysfunction-associated fatty liver disease, suggesting a need for metabolic risk assessment.

Key Points

  • This study examines the impact of metabolic dysfunction-associated fatty liver disease on liver fibrosis in chronic hepatitis B patients.
  • Cross-sectional analysis of 148 chronic hepatitis B patients categorized by MAFLD criteria.
  • Assessment of liver fibrosis using vibration-controlled transient elastography (VCTE).
  • Multivariate logistic regression to identify predictors of significant fibrosis.
  • 34.5% of chronic hepatitis B patients met MAFLD criteria.
  • CHB/+MAFLD group had a significant fibrosis prevalence of 45.1%, compared to 23.7% in CHB/−MAFLD (p < 0.001).
  • MAFLD increased odds of significant fibrosis (odds ratio 4.48, 95% CI 1.29–15.6, p 0.019).

Cite This Study

Mostafa et al. (2026) studied this question.

synapsesocial.com/papers/6a3f6843aea7db3c1953f763https://doi.org/10.1038/s41598-026-58144-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection2023 · 22 citations
  2. 2Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population2024 · 12 citations
  3. 3Retrospective analysis of predictors for significant hepatic inflammation in metabolic-associated fatty liver disease with chronic hepatitis B2026
  4. 4Clinical characteristics of metabolic dysfunction-associated steatotic liver disease and its association with significant liver fibrosis in hospitalized patients with chronic hepatitis B: a single-center retrospective cross-sectional study2026
  5. 5[Altered oral microbiome and metabolites are associated with improved lipid metabolism in HBV-infected patients with metabolic dysfunction-associated fatty liver disease].2025 · 2 citations